Acute ST segment elevation is regarded generally as the sine qua non of evolving Q wave myocardial infarction (MI) because such electrocardiographic (ECG) injury is believed to be a marker of transmural ischemia and a forerunner of transmural necrosis. Alternatively, ST segment depression with or without T wave inversion is viewed as the dominant ECG feature of non-Q wave MI. However, this hypothesis has not been assessed prospectively in an acute MI population. We analyzed 2,304 serial ECGs at study entry (admission), day 2, day 3, and predischarge (mean, 10.2±2 days) from 576 patients with creatine kinase MB 
Acute ST segment elevation is regarded generally as the sine qua non of evolving Q wave myocardial infarction (MI) because such electrocardiographic (ECG) injury is believed to be a marker of transmural ischemia and a forerunner of transmural necrosis. Alternatively, ST segment depression with or without T wave inversion is viewed as the dominant ECG feature of non-Q wave MI. However, this hypothesis has not been assessed prospectively in an acute MI population. We analyzed 2,304 serial ECGs at study entry (admission), day 2, day 3, and predischarge (mean, 10.2±2 days) from 576 patients with creatine kinase MB confirmed acute non-Q wave MI to determine what percentage of patients with early ST segment elevation culminated in subsequent Q wave development. Of this group, 187 patients (32%) exhibited 1 mm or greater ST segment elevation in two or more contiguous entry ECG leads. Of those patients whose non-Q wave MI could be localized on the basis of diagnostic admission ST segment shifts, the prevalence of early ST segment elevation was 43% (187 of 439). The sum total mean (±SD) peak ST segment elevation by lead group (anterior, inferior, lateral) was 4.0±2.4, 4.5±2.4, and 2.5±0.6 mm, respectively. Despite this, only 20% of patients with ST segment elevation (37 of 187) developed Q waves. Of 252 patients who exhibited early ST segment depression or T wave inversion or both, 39 (15%) evolved subsequent Q waves. Thus, while the prevalence of early ST segment elevation in acute evolving non-Q wave MI was higher than previously reported, 80% of patients with and 85% of patients without ST segment elevation and absent Q waves on the admission ECG did not develop subsequent Q waves during a 2-week period of observation (p=NS). In addition, when patients with ST segment elevation were compared with patients with ST segment depression or T wave inversions or both, there were no between-group differences in log peak creatine kinase ( Accordingly, the objectives of the present study were to 1) identify the proportion of patients with evolving non-Q wave MI who exhibited initial ST segment elevation and to compare their clinical, enzymatic, and prognostic profiles with patients who exhibited ST segment depression or T wave changes or both on admission; and 2) determine (within the small subgroup of patients who subsequently evolved n wave infarction) the accuracy of the ECG site, distribution, and extent of early ST segment elevation in predicting subsequent evolution of electrocardiographic Q waves.
Methods
The Diltiazem Reinfarction Study,26 initiated in 1982 and completed in 1985, contains a prospective data bank on 576 patients with acute non-Q wave MI. A total of 1,536 patients from nine enrolling sites (seven in the United States and two in Canada) were screened to assess eligibility for enrollment to the study on presentation to the emergency department with prolonged chest pain (.30 minutes). All patients were admitted to the coronary care unit, where the initial screening took place. The diagnosis of MI was confirmed by serial elevated CK and plasma MBCK, and after informed written consent, patients were randomly assigned to receive treatment with either diltiazem (n = 287) or placebo (n = 289) in addition to standard care. Thus, 576 of 1,536 unselected screened patients (36%) were subsequently randomized, all of whom had initially absent Q waves. Each patient satisfied specific inclusion and exclusion criteria,26,27 and medication was initiated 53 ± 14 hours (range, 24-72 hours) after onset of infarction, beyond the interval when initial ECG assessments were made. The organization and conduct of the Diltiazem Reinfarction Study, as well as baseline characteristics of patients according to treatment group assignment, were reported previously.26 '27 Clinical and Laboratory Evaluation After randomization, the following evaluations were performed: 1) daily clinical evaluation by the center investigator; 2) 12-lead ECG on enrollment and daily for the first 5 days, followed by every other day thereafter until 14 days or hospital discharge; 3) ECG at the time of recurrent pain and for a minimum of 3 consecutive days if reinfarction was suspected; and 4) serial blood samples for analysis of total CK and MBCK activity. All protocol samples were forwarded to the CK Core Laboratory for quantitative analysis for plasma MBCK activity by the batch absorption glass bead method.28'29 Sampling times consisted of an initial sample at the time of randomization, followed by samples drawn every 12 hours thereafter throughout the 14-day study. Additional samples were obtained at least every 8 hours for the subsequent 72 hours in patients in whom reinfarction was suspected.
Treatment Regimen
Diltiazem hydrochloride or identical placebo was given every 6 hours orally for up to 14 days. Titration began with a 30-mg tablet and was increased by 30 mg every 6 hours up to a maximal dose of 360 mg/ day diltiazem or placebo. Maximal tolerated dosing was achieved as soon as clinically possible.
All patients received standard medical therapy in accordance with local guidelines. Concurrent treatment with other calcium-channel blockers was pro- total inferior ST elevation with either anterior or lateral elevation were performed after multiplying the inferior total by a factor of 4/3. This was done to adjust for the difference in the number of leads in the anterior and lateral lead groups (four each) as compared with the inferior location (three leads). transformed ranks produced data that approximated the normality and equal variance requirements of t tests and analyses of variance far better than either the original variables or other available transformations such as the logarithm and square root. Figure 1 shows ECG findings among the 576 patients who were enrolled in the Diltiazem Reinfarction Study. There were 32 patients (5.5%) who, in retrospect, had an acute Q wave MI on entry into the trial; these patients were censored from further analysis. Of the 544 remaining patients with acute non-Q wave MI, 187 (34%) exhibited admission ST segment elevation associated with the MBCKconfirmed event. Because 105 of the 544 patients (19%) had nonlocalizable non-Q wave MI, as defined previously, the true prevalence of ST segment elevation among patients whose infarcts could be localized by diagnostic ST segment shifts on the admission ECG was 43% (187 of 439). Figure 5) . Conversely, six of 11 patients (55%) with inferior ST segment elevation of 2.0 mm or more per lead progressed to subsequent Q wave MI ( Figure 5) There were no differences in the site of qualifying infarct by ECG, peak CK, or the time to peak CK, nor was the incidence of post-MI angina and reinfarction in patients with ST segment depression or T wave inversion or both different compared with those patients with early ST segment elevation.
Results

Clinical Characteristics
Sensitivity, Specificity, and Predictive Value of ST Segment Shifts in Evolving Non-Q Wave MI As noted above, analysis for site of MI among the 187 patients with ST segment elevation showed only 16% of the patients (21/133) with anterior ST segment elevation progressed to Q wave MI (Figure 6 ). There was a significant negative association for developing Q wave MI if the initial ECG showed anterior ST segment elevation (p = 0.031). Conversely, of the 52 patients with inferior ST segment elevation, 16 (31%) progressed to Q wave MI leading to a significant positive association of developing Q wave MI (p= 0.019). There were too few lateral non-Q wave infarctions with isolated ST segment elevation to permit a statistical analysis in this group. Table 3 summarizes the sensitivity, specificity, and predictive value of ST segment shifts for the subsequent development of Q waves in the Diltiazem Reinfarction Study population. ST segment elevation for both anterior and inferior MI was poorly predictive of subsequent Q wave evolution. Somewhat surprisingly, early ST segment depression was more predictive of subsequent Q wave evolution (30%) than early ST segment elevation (16%) for anterior non-Q wave infarction, but the reverse was true for inferior infarction. Discussion In the Diltiazem Reinfarction Study of early non-Q wave MI, 576 patients were enrolled and followed prospectively with serial analysis of ECGs and plasma CK and MBCK determinations. Paradoxically, one third of the patients (187 of 576), despite initial non-Q wave MI only, exhibited ST segment elevation on admission to the hospital. Subgroup analysis showed that of patients presenting with ST segment elevation, 80% did not evolve new Q waves; in the group presenting with ST segment depression or T wave inversion or both, 85% of the patients did not evolve new Q waves.
Moreover, the presence or absence of admission ST segment elevation was not associated with significant differences in the incidence of subsequent reinfarction or post-MI angina. In patients with early anterior ST segment elevation, there was no significant correlation between the magnitude or extent of ST segment elevation and the subsequent development of Q waves. However, early inferior ST segment elevation was more frequently associated with subsequent Q wave evolution, although the explanation for this finding is uncertain. One possibility is that collateral blood flow to the anterior wall was less jeopardized than to the inferior wall in this study population, which might explain the higher rate of Q wave development in the latter group. Feldman and coworkers34 have shown that, compared with patients with reversible ST segment depression, those patients who exhibited reversible ST segment elevation during left anterior descending (LAD) coronary artery occlusion had less severe degrees of LAD stenosis and uniformly absent collaterals to the distal LAD bed. Persistent ST segment depression complicating early non-Q wave MI, however, may be a marker of more severe ischemia and subsequent Q wave evolution, particularly in those patients with initial anterior non-Q wave MI.
Electrocardiographic Pattem of Q Wave and Non-Q Wave Infarction
Non-Q wave MI generally is defined electrocardiographically by the absence of abnormal Q waves (>0.03 seconds in two or more leads) or "Q wave equivalent" (i.e., R wave>0.04 seconds in lead V1 and R: S> 1 in lead V2) and is usually characterized by ST segment depression, with or without an abnormal T wave. 35 It is curious that evolving acute non-Q wave infarction is not typically regarded as one of the clinical settings in which acute ST segment elevation may occur.
The fact that 43% (187 of 439) of all non-Q wave MI patients with initially "localizable" infarcts by ECG in our study (and 32% of all non-Q wave MI patients) exhibited ST segment elevation is a noteworthy observation. Of importance is that of the 162 patients who exhibited ST segment elevation confined to a single ECG lead group, 57 (35%) exhibited more than 2 mm ST segment elevation per lead (Figure 3 ), yet only 13 of 57 (23%) developed new Q waves ( Figure 5 ). Thus, it is apparent that the specificity of early ST segment elevation in the diagnosis of evolving Q wave MI is much less than previously suspected and that ECG ST segment elevation, while clearly a marker of transmural ischemia, may not invariably culminate in transmural infarction and subsequent Q wave evolution. Although DeWood and coworkers did not quantify the proportion of individuals with non-Q wave MI who exhibited ST segment elevation before cardiac catheterization, their observation that spontaneous reperfusion occurred commonly during the 1st week (especially within the first 72 hours) after non-Q wave MI supports the hypothesis that acute ST segment elevation without progression to Q waves is indicative of coronary obstruction with subsequent early recanalization and attendant myocardial salvage.
Finally, a recent Diltiazem Reinfarction Study data bank analysis showed that a minority of non-Q wave MI patients with acute precordial ST segment depression, interpreted at study entry as classic anterior subendocardial necrosis, developed pathologic R waves in leads V1-V2 on subsequent review of serial ECGs.37 A detailed review of these tracings showed a characteristic pattern of horizontal or downsloping ST segment depression with upright T waves in the precordial leads, indicative of posterior wall injury. Because of the reciprocal nature of these acute repolarization changes, early transmural ischemia of the posterior wall may be manifest initially as precordial ST segment depression, which later evolves into a Q wave equivalent posterior transmural MI.36 Clinical Implications
Our observations may have important clinical implications, particularly in deciding which infarct patients should be selected for acute thrombolytic therapy. Most current guidelines for patient selection involving streptokinase or recombinant tissue plasminogen activator require the presence of only 1 mm of ST segment elevation in two or more ECG leads.12-14 ST segment depression is generally regarded as an exclusion criterion. Because it is not possible to differentiate with precision those patients with acute ST segment elevation indicative of transmural ischemia who will evolve Q waves from those with transmural ischemia who will not, some patients (particularly non-Q wave MI patients) may receive thrombolytic therapy but would likely have undergone spontaneous coronary reperfusion anyway. Whether there would be additional myocardial salvage in such non-Q wave MI patients who receive thrombolytic therapy has not been addressed scientifically and must await future study.
Conversely, many patients who exhibit ST segment depression (particularly patients with occluded or subtotally occluded circumflex or posterior descending coronary arteries37 '38) and would be appropriate candidates otherwise for thrombolytic therapy are presently excluded from receiving such potentially life-saving thrombolytic therapy. A priori, there is no scientific basis for excluding patients with ST segment depression, especially when such occurrences reflect transmural ischemia of the posterior or lateral wall, and not trivial subendocardial ischemia.
Related to this issue of interpreting the proper significance of ST segment depression during prolonged myocardial ischemia is the recent observation that ST segment depression complicating acute non-Q wave MI is a major predictor of adverse long-term prognosis.39 '40 We have observed that ST depression, whether measured on the admission ECG or on the discharge ECG, was associated with a two-fold higher incidence of reinfarction and death at 1-year, compared with patients with either ST segment elevation or T wave inversion or both.39'40 Moreover, we have shown that persistent ST segment depression that is seen on both the admission and discharge ECG is an independent risk factor for increased late mortality. 41 The mortality rate among 515 non-Q wave MI patients without any ST segment depression was 5.5%, compared with 10.1% in patients with ST segment depression on either the admission or discharge ECG, and 22.2% in patients with ST segment depression on both ECGs.
Investigators for the MILIS Study have also reported that non-Q wave MI patients with ST segment depression are a high-risk group of patients with a poor long-term outcome,36 similar to our own findings. Why ST segment depression appears to be a marker of adverse long-term prognosis is not presently clear, but studies suggest that impaired, or threatened, collaterals may be a prominent feature in those non-Q wave MI patients who are prone to repetitive ischemic events.34,42,43
Summary
We believe our data show that ST segment elevation is a prevalent finding in early acute non-Q wave MI and does not necessarily presage the development of Q waves. Moreover, these data indicate that ST segment shifts (elevation or depression) may indicate transmural ischemia that may not invariably culminate in transmural infarction and that ST segment depression should not be considered inherently more "benign" than ST segment elevation. Finally, decisions to proceed to early thrombolytic therapy should not be predicated solely on the arbitrary adoption of prespecified thresholds of ST segment deviation because either ST segment elevation or depression may be associated with comparable degrees of coronary luminal narrowing. 34 The role of thrombolytic therapy in patients with evolving MI characterized chiefly by ST segment depression remains to be elucidated.
